Trial Profile
Effect of bortezomib in patients with systemic amyloid Light-chain (AL) amyloidosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2015
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Cyclophosphamide; Dexamethasone; Melphalan
- Indications Amyloid light-chain amyloidosis
- Focus Therapeutic Use
- 13 May 2015 New trial record